Introduction
Although the placental entry of some infections is a critical aspect of these infections, the role of placental cells and the mechanism by which pathogens pass from the maternal to the fetal circulation varies. The placenta provides a barrier that prevents transmission of some viruses, but allows others to reach the fetal circulation. Mother to fetus placental transmission of some viruses occurs through transcytosis across placental cells. The placenta may also act as a reservoir in which virus replicates before reaching the fetus.
Some viruses as cytomegalovirus may pass across syncytiotrophoblasts or through cytotrophoblasts within the uterine wall. 1 Complete cytomegalovirus replication can happen in trophoblasts and fetal endothelial capillary cells. 2 The susceptibility of trophoblast cells to infection by other viruses, such as adenovirus and herpes simplex virus, reduces as trophoblasts differentiated into syncytiotrophoblasts due to decreased expression of the viral receptors. 3 Hepatitis B virus transcytosis may occur across the undifferentiated trophoblasts early in pregnancy. 4 In HIV-1-infected mothers with no protective antiretroviral therapy during pregnancy, trophoblasts have the viral sequences. 5 However, more than 90% of their infants are protected against HIV-1 during pregnancy. 6 The antiretroviral therapy, zidovudine (ZDV) is metabolized into its active form in the placenta. 7 ZDV inhibits HIV replication within placental cells. To reach the fetal circulation, HIV-1 should cross the trophoblastic placental barrier (cytotrophoblasts and syncitiotrophoblasts). Blood borne maternal pathogens that arrive at the uteroplacental circulation and intervillous space may reach the fetus through the villous capillaries. HIV-1 has been detected on both the maternal and the fetal parts of the placenta. HIV-1 experiences replication in the placenta. The virus may cross the trophoblastic barrier by endocytosis, or by an injured villous surface. However, superficial breaks in syncytiotrophoblast cells do not radically affect the vertical transmission of viruses. 8 
Placental overview: pathophysiology and immunology
The placenta is made up of chorionic villi (fetal capillaries and villous stroma) and trophoblast cells (syncytiotrophoblasts and cytotrophoblasts). Placentation consists of two major processes: implantation (blastocyts attachment to the uterine wall) and chorionic villi formation (development of the embryo's blood vessels and their attachment into the uterine wall). The uterineplacental interface forms a membrane, the placental membrane (blood placental barrier) which separates the fetal blood from the maternal blood. The placental membrane contains fetal vascular endothelium, connective tissue, trophoblast and syncytium. The placental membrane grows to be thinner as pregnancy advanced. There are two susceptible passageways of infectious agent from mother to fetus: the fetal membranes which give direct access to pathogens ascending from the vagina and cervix and the placental intervillous space and fetal villi which give hematogenous access from maternal blood to fetal blood.
The chorionic villous contains macrophages (Hofbauer cells) and fetal blood vessels. Cytotrophoblasts differentiate into two pathways: floating villi and anchoring villi. In the floating villi, cytotorphoblast cells fuse to form multinucleated syncytiotrophobals at around 12 weeks of gestation. Anchoring villi attach the placenta to the uterine. Syncytiotrophoblasts are in direct contact with the maternal blood. Deciduas contain granular leukocytes, natural killer cells, macrophages, dendritic cells and T lymphocytes. The torphoblast cells and the terminal villi have CD4 receptors 9 which can be infected by HIV-1. HIV-1 genomic materials have been detected in placental macrophages (Hofbauer cells), cytotrophoblasts and syncytiotrophoblast. [10] [11] [12] HIV-1 replication and transmission through the placenta may occur through CD4-positive endothelial tissues or CD4-positive Hofbauer cells. Other findings concluded that placental macrophages form a barrier to primary HIV-1. 13 Histolopathological and immunological examination of the placenta can determine the presence of intrauterine infection. Pathological features of placental inflammation may not always be connected with microbiological evidence of an infectious pathogen. The histological examination of the full-term placenta from HIV-1-positive women revealed HIV-1 infection in syncytiotrophoblasts, cytotrophoblasts and villous-endothelial cells. The histopathology of a 16-week placenta revealed that both the syncytiotrophoblast and cytotrophoblast appear to be infected with HIV-1.
11 HIV-1 was rarely found in chorionic villi in seropositive mothers.
14 A study of in vitro model of trophoblast barrier found that the direct contact between the trophoblast barrier and HIV-1-infected cells (not the cell free virus) can lead to viral transcytosis across the trophobast cells layer. 15 Viral transmission depends on maternal viral load 16 and the level of maternal antiviral antibodies. 17 No threshold value of virus load have been identified to distinguish between transmitting and nontransmitting mothers. 18 However, high maternal viral load is insufficient to completely explain vertical transmission of HIV-1.
Several studies have evaluated anti-HIV-1 antibody-dependent cellular cytotoxicity T-cells (ADCC) titer in sera of infants born to HIV-1-infected mothers and found that these antibodies are transferred efficiently across the placenta from the mother to her fetus. 19 However, high levels of anti-HIV-1 ADCC antibody at birth are not protective against vertical transmission of HIV-1. 20 Perinatal transmission of HIV-1 is characterized by selection of specific genotype variant in the infected infant 21 that escapes the mother's immune system. Normally, HIV-1-specific cytotoxic T-lymphocyte (CTL) immune response is strongly associated with low viral load and nonprogression of HIV-1 infection.
22,23 CTL escape may be related to mutation within human leukocyte antigen-class 1 (HLA-1), limited CTL epitopes 24 and loss of viral identification. 25, 24 Therefore, enhancing the cellular immunity and decreasing the immune escape may decrease the perinatal HIV-1 transmission. 26 The commonest pathological feature in the placenta of HIV-1 seropositive mothers is chorioamnionitis and the commonest noninflammatory lesion is cytotrophoblastic hyperplasia. 27 There is no relationship between the incidence of placental pathological lesions and the HIV status of the newborn. The incidence of chorioamnoinitis increases in HIV-1-infected women. 28 Concomitant placental infection may increase risk of placental transmission of HIV-1 to the fetus. Co-infections may stimulate the HIV-infected cells to produce more viruses. For example, Plasmodium falciparum in placental trophoblasts could stimulate HIV-1 replication and increase the risk of HIV-1 transmission in utero.
29
Genetic characteristics of HIV-1 sequences from infected mothers with subsequent perinatal transmission to the fetuses HIV can infect different cells such as CD4-positive T cells and macrophages (Hofbauer cells) that express CD4 on their surface. HIV-1 entry to macrophages and T cells is mediated by interaction of envelope glycoproteins (gp120) with the CD4 molecule on the target cells and with the chemokine co-receptors ( Table 1 ). The env protein has two parts: gp120 (surface envelope glycoprotein) and gp41 (transmembrane envelope glycoprotein). Gp120 is located outside the virion and it has a role in the fusion (cell to cell and virus to cell). CD4 T-lymphocytes receptor in the host cell act as a binding receptor for HIV surface envelope glycoprotein (gp120). Tranmembrane envelope glycoprotein (gp41) connects the surface envelope glycoprotein (gp120) to the viral membrane. Gp41 promotes fusion of the virus with the plasma membrane of the host cells leading to virus entry. There is a low degree of HIV-1 envelope gp41 heterogeneity in transmitting mothers as compared with nontransmitting mothers. 30 The env gene has five variable regions (V1 to V5). Limited heterogeneity of env (V3) region of HIV-1 in infected mothers associated with lower chance of vertical transmission. 31 An intact and functional gag p17 matrix is maintained during maternal-fetal transmission. 32 Specific amino acids motifs in p17 may be associated with perinatal transmission. 32 Gag p17 heterogeneity is higher in transmitting mothers 33 than gag p17 heterogeneity in nontransmitting mothers. 32 The HIV-1 nucleocapsid, P7 and p6 open reading frames and functional domains are conserved following HIV-1 vertical transmission. 34 The regulatory genes tat and rev, and the accessory genes vif, vpr, vpu and nef are essential for HIV-1 replication in host cells. 35 Vif and vpr sequences of transmitting mother are more heterogeneous than those of nontransmitting mothers. 31, 36 There is a high degree of conservation of vif and vpr functional domain in transmitting mothers. 36 In transmitting mothers, the variability of vpu genes found to be higher than that seen for other HIV-1 genes, including vif, vpr, tat and gag p17. 37 The functional domains essential for vpu activity are conserved in transmitting mothers, including efficient release of virus particles from infected cells. 37 An intact and functional tat gene is conserved in HIV-1 from transmitting mothers. 38 Preservation of intact nef open reading frames with conserved functional domains and a low degree of genetic variability has been associated with HIV-1 vertical transmission. 39 Conservation of functional domains of rev and a low degree of heterogeneity is associated with HIV-1 vertical transmition. 40 Rev is considered the most functionally conserved regulatory protein of lentiviruses.
The reverse transcriptase enzyme of HIV-1 is important in the life cycle of the virus by converting the single-stranded RNA genome into double-stranded DNA that integrates into the host chromosome. There is a lower degree of viral heterogeneity in transmitting mothers compared with nontransmitting mothers. 41 Human chorionic gonadotropin (hCG) has been shown in vitro to inhibit reverse transcriptase and to block viral transmission between virus-carrying lymphocytes and placental trophoblasts. 42 However, role of hCG in protecting the fetus from vertical transmission HIV-1 needs to be studied. In summary, the restricted heterogeneity of HIV-1 in the infected mothers is more likely associated with lack of vertical transmission.
Chemokines
Placental cells produce enormous group of soluble factors and receptors such as major histocompatibility complex (MHC) class I molecules including HLA-G, cytokines, chemokines and hormones. 42 Chemokines and cytokines with an effective anti-HIV-1 activity have been detected in human placentas. 42, 43 Placental cytokines and chemokines may influence HIV replication in trophoblasts. Alternatively, cytokines, such as inflammatory cytokines, facilitate HIV infection and replication during pregnancy.
HIV uses chemokine receptors to enter the host cells. The chemokine receptors CCR5 and CXCR4 serve as the major coreceptors for HIV-1. The co-receptors are very important for HIV-1 infectivity and tropism. Nonsyncytium-inducing strains utilize CCR5 as a co-receptor and are identified as R5 strains. 44 Syncytium-inducing isolates utilize CXCR4 as a co-receptor and are identified as X4 strains. 45 R5 strain is the most commonly transmitted strain through vertical transmission. 46 Placental tissues contain detectable levels of chemokines receptors.
14 HIV-1 gp120 contains the binding site for the CD4 receptor and the seven transmembrane domain chemokine receptors that serve as co-receptors for HIV-1. Gp120 binds to co-receptors (CCR5) which is necessary for the entry of R5 virus. 47 The V3 region of env gene is responsible for interaction with coreceptors 48 and it is essential for cellular tropism. 49 Infants who were homozygous for 32-bp deletion for CCR5 were not infected by HIV-1-positive mothers. 50 Maternal antibodies to HIV-1 co-receptors are able to cross the placenta and downregulate CCR5 and CXCR4 receptors. 51 Vaccines that induce chemokine expression result in downregulation of HIV-1 co-receptors and this may complement HIV-1-specific cellular and humoral protection. 19 Cytokines Pregnancy has been defined as Th2-type immune response. Helper T cells have two significant functions: to stimulate cellular immunity and inflammation, and to stimulate B cells to produce antibodies. Two functionally different subsets of T cells secrete cytokines which promote these distinct activities. Placentas from nontransmitting mothers sustain a strong Th2 cytokine environment, whereas placentas from transmitting mothers demonstrate a Th1 predominance. 52 CCR5 expression is upregulated by Th1 cytokines, whereas CXCR4 expression is upregulated by both Th1 and Th2 cytokines. 25, 53 Expression of inflammatory cytokines is elevated in trophoblasts with a high level of HIV transcripts. 54 Th2 cytokines and low CCR5:CXCR4 may probably reduce placental HIV-1 replication. A recent study demonstrated a fourfold increase in CCR5:CXCR4 ratio in placentas from transmitting mothers compared with placentas from nontransmitting mothers. 52 Interleukin-4 (IL-4) upregulates production of the leukemia inhibitory factor (LIF), an IL-6 class cytokine. LIF is a potent inhibitor of HIV-1 replication and it is upregulated in the placenta of nontransmitting mothers. 52 IL-1 and tumor necrosis factor-a stimulate the HIV transcription in trophoblasts. 55 Interferon-a (IFN-a) and IFN-b inhibit the HIV transcription. 56 A connection between in utero vertical transmission of HIV-1 and expression of Th2 cytokines (IL-4 and IL-10) and LIF has been described. 25, 52 Whether these factors may possibly limit HIV-1 infection of the trophoblasts remains to be clarified.
Conclusion
Placenta has a fundamental role in the vertical transmission of HIV from the mother to the fetus. The mechanism of in utero transmission of HIV-1 is poorly understood. Several indications support direct implication of the placenta, but a little information is known about the mechanism by which the virus can cross the placenta, the pathologic consequences of placental viral infection. Several mechanisms have been proposed to explain the protection of the fetus against maternal HIV during pregnancy. The placental structure and function change throughout pregnancy and the differentiation of trophoblast cells to syncytiotrophoblast generate a barrier that may protect the fetus from viral infections. The placental transmission of HIV is influenced by maternal viral load and maternal immune response as well as the presence or absence of pathological condition of the placenta. The primary receptor HIV-1 is CD4, which was recognized early in the studies of HIV pathogenesis. The macrophage topic viral strain of HIV-1 (R5 virus) is the most commonly transmitted strain through vertical transmission. Transmission through the placenta may occur through CD4-positive endothelial tissues or CD4-positive Hofbauer cells. The trophoblast cell and the terminal villi have CD4 receptors, which also make them potential candidates for HIV transmission. CD4 is an essential, but not a sufficient, factor for HIV-1 entry and replication. Chemokine receptors, in combination with CD4, mediate the efficient entry of HIV into cells including placental cells. Transmission of HIV-1 is characterized by selection of genotype variant in the infected child that escape the mother's immune system. Genetic analysis of HIV-1 sequences help to determine the interaction between HIV-1 and placental tissue. HIV-1 genes influence the transmission and pathogenesis of HIV-1. The third variable region (V3) of HIV-1 is responsible for interaction with the chemokine co-receptor which may be present in some of these cells. The other genes tat, rev, vif, vpr, vpu and nef are required for HIV-1 replication in host placental cells. Restricted heterogeneity of HIV-1 in the infected mothers associated with lack of vertical transmission. Placental cells produce soluble factors and receptors such as MHC class I molecules including HLA-G, cytokines, chemokines, and hormones protect the infants from HIV-1 infection. However, cytokines, such as inflammatory cytokines facilitate HIV infection and replication in different cell types, are also expressed during the various phases of pregnancy. HCG has been shown in vitro to block viral transmission between virus-carrying lymphocytes and placental trophoblasts.
